ILC2-deficient mice (Roraf/fIl7rCre/+Apc1322T/+ mice) also developed fewer tumours, which correlated with increased frequencies of Th1 cells and CD8+ T cells, and a reduction in MDSCs. The gene discussed is CD8A; the disease is neoplasm.